Characterization of Serum Growth Hormone (GH) and Insulin-Like Growth Factor I in Active Acromegaly with Minimal Elevation of Serum GH*

作者：William H. Daughaday, Ralph H. Starkey, S. Saltman, James R. Gavin, BONNIE MILLS-DUNLAP, Ellen Heath-Monnig · 发表于：The Journal of Clinical Endocrinology & Metabolism · 年份：1987 · DOI：10.1210/jcem-65-4-617 · 被引用次数：54 · 研究领域：Pituitary Gland Disorders and Treatments、Growth Hormone and Insulin-like Growth Factors、Ophthalmology and Eye Disorders

In most patients with acromegaly basal serum GH concentrations are elevated and remain above 5 micrograms/L after oral glucose administration. In some patients, however, serum insulin-like growth factor I (IGF-I) concentrations are elevated with only minimal elevations of serum GH. We studied the serum GH and IGF-I of two such patients to determine whether these peptide hormones are normal in this clinical situation. The serum GH of these patients was found to bind normally to receptors of the IM-9 lymphocyte. The elution pattern of IGF-I extracted from the patients' serum was similar to that of (Thr59) human IGF-I after passage through a Bio-Rad P-60 column in 0.5 M acetic acid. The IGF-I was further characterized by isoelectric focusing and C18 reverse phase high pressure liquid chromatography (HPLC). The isoelectric points of the IGF-I components were similar to those of IGF-I in normal serum. The IGF-I in one patient had two components by HPLC, while that of the other patient had only one major component. The IGF-I components isolated by HPLC were normally active in stimulating [3H] alpha-aminoisobutyric acid uptake by normal human fibroblasts. The elevated serum IGF-I concentrations of these two patients were GH dependent. Transsphenoidal adenomectomy in one patient resulted in a decline in serum IGF-I to a high normal concentration. Lowering the serum GH to subnormal concentrations by the administration of the somatostatin analog SMS 201-995 (Sandoz) restored normal IGF...